Option Care Health (NASDAQ:OPCH) Stock Rating Upgraded by Jefferies Financial Group

Option Care Health (NASDAQ:OPCH) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Marketbeat reports. The firm currently has a $35.00 target price on the stock, up from their previous target price of $26.00. Jefferies Financial Group’s target price suggests a potential upside of 19.41% from the company’s current price.

Other analysts also recently issued research reports about the stock. Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.14.

Option Care Health Stock Performance

Shares of OPCH stock opened at $29.31 on Thursday. The firm has a 50-day moving average of $24.10 and a 200-day moving average of $27.78. The company has a market cap of $4.99 billion, a P/E ratio of 24.63, a P/E/G ratio of 2.12 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health has a one year low of $21.39 and a one year high of $34.63.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in OPCH. FMR LLC increased its stake in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares during the period. Victory Capital Management Inc. boosted its holdings in Option Care Health by 4,432.8% in the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after acquiring an additional 1,585,818 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after acquiring an additional 1,328,326 shares in the last quarter. Duquesne Family Office LLC boosted its holdings in Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after acquiring an additional 1,185,613 shares in the last quarter. Finally, Geneva Capital Management LLC bought a new stake in Option Care Health in the third quarter valued at $24,679,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.